The inhibition of TGF‐β/TβRII‐Akt‐Myogenin signalling by SPSB1 may shed light on the pathogenesis of the perturbed regenerative capacity observed in muscle of critically ill patients with sepsis (Figure S19). This evidence concerns the gene TGFBR2 and Sepsis.